A nuclear verdict is a jury award of $10 million or more, driven by pain-and-suffering and punitive damages far above the plaintiff's actual losses.
A nuclear verdict is a jury award of $10 million or more against a defendant. The term describes an outsized civil award. The payout runs far above the plaintiff's real losses, driven mostly by pain-and-suffering and punitive damages. Awards above $100 million are called thermonuclear verdicts. For commercial P&C carriers and MGAs, a nuclear verdict is more than a legal event. It is a severity shock that lands on the casualty loss ratio and on prior-year reserves.
What counts as a nuclear verdict?
A nuclear verdict is any single jury award at or above $10 million. That $10 million line is the standard threshold used by the leading corporate-litigation tracker (Marathon Strategies, 2025). Two larger tiers sit above it. A thermonuclear verdict is $100 million or more. A mega verdict crosses $1 billion. The tiers matter to underwriters because each one breaches a different layer of a program.
| Tier | Award size | 2024 count | What it signals for underwriting |
|---|---|---|---|
| Nuclear verdict | $10 million or more | 135 | Severity shock to the casualty loss ratio |
| Thermonuclear verdict | $100 million or more | 49 | Reserve strain and reinsurance-attachment risk |
| Mega verdict | $1 billion or more | 5 | Tail risk that can breach excess and umbrella towers |
Source: Marathon Strategies, Corporate Verdicts Go Thermonuclear, 2025 edition (2024 data).
How large is the nuclear verdict problem?
Nuclear verdicts hit a record in 2024. Companies faced 135 nuclear verdicts that year, the most on record, across 34 states (Marathon Strategies, 2025). Their total value reached $31.3 billion. That total was up 116% from 2023, and the count itself rose 52% in one year. Of those awards, 49 crossed $100 million and 5 crossed $1 billion. Since 2020, the number of nuclear verdicts is up 309% and the median award is up 143%. The trend is not a spike. It is a steady climb in severity.
Why are nuclear verdicts rising?
Nuclear verdicts rise with social inflation, not with general prices. Social inflation is the rise in liability claim costs above general economic inflation (NAIC). Three forces push it up. Juries are more willing to punish corporate defendants. Plaintiff attorneys anchor juries on very large numbers. Third-party lawsuit funding pays for longer, larger cases. That funding was a roughly $17 billion global industry as of 2021, with over half spent in the United States (NAIC). Industry research linked to the Casualty Actuarial Society found social inflation added about $20 billion to commercial auto liability claims between 2010 and 2019 (Insurance Information Institute, 2022).
Which lines of business are most exposed?
Commercial auto and trucking carry the heaviest exposure. Auto accidents made up 22.8% of nuclear verdicts. That sits just behind product liability at 23.6% and ahead of medical liability at 20.6% (US Chamber Institute for Legal Reform, 2022). In trucking, the median nuclear verdict reached $36 million in 2022, about 50% higher than in 2013 (American Transportation Research Institute, 2024). More than 80% of trucking verdicts above $1 million carried non-economic damages up to ten times the actual medical bills. General liability, excess, and umbrella layers feel the same severity because they sit above the primary layer.
How do nuclear verdicts affect underwriting?
Nuclear verdicts turn a single account into a loss-ratio event. One $10 million award can wipe out the premium from hundreds of clean accounts in the same book. The damage grows as old reserves prove too low. The claim was priced and reserved years before the verdict landed, so the shortfall hits a prior year. US commercial auto has now run 14 straight years of underwriting losses. That includes a $4.9 billion net underwriting loss in 2024 (AM Best, 2025). Rate alone has not closed the gap. Loss size is rising faster than price. This is why 14 years of rate hikes still have not fixed the line, and why the combined ratio stays above 100.
What can underwriters do about nuclear verdicts?
Underwriters cannot control juries, but they control the data behind selection and pricing. The controllable lever sits upstream. It is the accuracy of exposure, fleet, and prior-loss data captured at submission. A missed prior claim or a wrong vehicle count changes the risk grade and the attachment point. Clean, field-level accurate intake data lets an underwriter spot the lawsuit-prone account before bind. It also lets them price the tail and set limits with eyes open. Accurate loss run data is the first place this discipline either holds or breaks. Pibit.AI supports this with AI extraction plus managed human-in-the-loop review. That model delivers 99.9% contractual field-level accuracy on loss runs and supplemental documents, so severity signals are not lost in the first mile. Better data accuracy at intake is the underwriting answer to a courtroom problem.
Frequently asked questions
What is the difference between a nuclear verdict and a thermonuclear verdict?
A nuclear verdict is a jury award of $10 million or more. A thermonuclear verdict is $100 million or more. In 2024, 49 of the 135 nuclear verdicts were thermonuclear, and 5 crossed $1 billion (Marathon Strategies, 2025).
Are nuclear verdicts covered by insurance?
Coverage usually applies only up to the policy limit. An award above that limit can exhaust primary coverage and pierce excess and umbrella layers. It can also expose the insured beyond its limits. This is why limit adequacy and attachment points matter at the underwriting stage, not just in claims.
How can carriers reduce nuclear verdict losses?
The underwriting lever is data accuracy before bind. Accurate prior-loss and exposure data lets underwriters select and price lawsuit-prone risk correctly, set the right limits, and attach higher where needed. Pibit.AI delivers 99.9% contractual field-level accuracy on loss runs and supplemental documents with AI plus managed human-in-the-loop review, so severity signals are not missed at intake.
